Does going to the moon still matter? Image

Does going to the moon still matter?

31 March - 19 mins
Podcast Series Science Weekly

If all goes to plan, Artemis II, Nasa’s mission to return humans to the moon, will launch this week. The mission will mark the farthest that humans have travelled from Earth, and the first return to the moon in more than 50 years. It will also pave the way for landing on the moon again as soon as 2028. But given the Apollo missions have already achieved that feat, does going back to the moon still matter today? To find out, Madeleine Finlay hears from the Guardian’s science editor, Ian Sample, the Atlantic journalist Ross Andersen, and Jan Wörner, a former director general of the European Space Agency. Help support our independent journalism at theguardian.com/sciencepod

19 mins

Series Episodes

Stateside with Kai and Carter: why the fight over abortion pills is only just beginning

Stateside with Kai and Carter: why the fight over abortion pills is only just beginning

The US supreme court has preserved nationwide access to mail-order abortion pills – for now. As Carter Sherman explains, the fight to protect this medication is far from over, as a nationwide, near-total abortion ban could be on the horizon. Carter speaks with Dr Angel Foster, co-founder of the Massachusetts Medication Abortion Access Project, who reveals how the legal battle over abortion pills has affected patients across the US – and what could happen next. Help support our independent journalism at theguardian.com/sciencepod

42 mins

23 May Finished

Can a name change transform PCOS outcomes for women?

Can a name change transform PCOS outcomes for women?

After more than a decade of global consultation, polycystic ovary syndrome – which affects as many as one in eight women – has been renamed. The condition is caused by high levels of androgens, which can lead to symptoms such as excess hair, weight gain and irregular periods. To understand why campaigners wanted it renamed, and what its new name – polyendocrine metabolic ovarian syndrome (PMOS) – could mean for patients, Madeleine Finlay hears from the Guardian’s science correspondent, Nicola Davis, and Rachel, a campaigner from the charity Verity. Help support our independent journalism at theguardian.com/sciencepod

16 mins

21 May Finished

Ebola: how does it spread and can the outbreak be contained?

Ebola: how does it spread and can the outbreak be contained?

An outbreak of Ebola has emerged in the Democratic Republic of Congo and Uganda, leading to nearly 400 confirmed cases and more than 100 deaths. To find out how the outbreak might have begun, what authorities can do to contain it and why this outbreak is causing particular concern, Ian Sample hears from Daniela Manno, a clinical epidemiologist at the London School of Hygiene and Tropical Medicine. Help support our independent journalism at theguardian.com/sciencepod

13 mins

18 May Finished

Stateside with Kai and Carter: Stacey Abrams on why gutting of the US Voting Rights Act is ‘evil’

Stateside with Kai and Carter: Stacey Abrams on why gutting of the US Voting Rights Act is ‘evil’

The US supreme court dealt a devastating blow to the 1965 Voting Rights Act when it ruled in Louisiana v Callais in April that states cannot consider race in redistricting. Southern states from Tennessee to Alabama have rushed to erase majority-Black districts, sparking chaos for the midterm elections. Kai Wright talks to Stacey Abrams, a voting rights activist and former Georgia house minority leader, about the fallout from the decision, and why, despite it all, she still believes the way forward lies in engaging more voters to participate in democracy. ‘They have fractured communities and said we’re going to scatter these seeds. Our job is to grow,’ she says. Help support our independent journalism at theguardian.com/sciencepod

35 mins

16 May Finished

Hantavirus update, Pentagon’s UFO files, can art slow biological ageing?

Hantavirus update, Pentagon’s UFO files, can art slow biological ageing?

Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eyecatching stories from the week, including an update on hantavirus. Also on the agenda is the Pentagon’s release of a tranche of never before seen documents relating to UFOs, and a study looking at the link between taking part in cultural activities and slower biological ageing. Help support our independent journalism at theguardian.com/sciencepod

21 mins

14 May Finished

Strange trip: why Trump is backing psychedelics

Strange trip: why Trump is backing psychedelics

Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise in relieving the long term effects of traumatic brain injury. Madeleine Finlay talks to journalist Mattha Busby about podcaster Joe Rogan’s role in the story, what else is behind the President’s interest in psychedelic research, and what the order will change in practice for scientists and researchers. Help support our independent journalism at theguardian.com/sciencepod

17 mins

12 May Finished

Recommended

Show name

Title

Sub title

Now Playing

The Pat Kenny Show

Live Now: 9AM - 12PM

Presenter logo
Brand

9AM

12AM

Now Playing

The Pat Kenny Show

The Pat Kenny Show

Of The Ball

1 hour left

Today Finished


Next Up

Default

Default

default

0 mins

No Account

Subscriptions to podcast series are only available to users with an account. Sign in or register to subscribe and access your subscriptions.

Register Sign in

Woops!

Error text.